Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: A marker for a worse prognosis
- 1 March 2001
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 141 (3) , 485-490
- https://doi.org/10.1067/mhj.2001.113219
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Diabetes and Cardiovascular DiseaseCirculation, 1999
- Is glucose a continuous risk factor for cardiovascular mortality?Diabetes Care, 1999
- The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.Diabetes Care, 1999
- The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular DiseaseEndocrine Reviews, 1998
- Fibrinogen Is a Predictor of Mortality in Coronary Heart Disease PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Asymptomatic hyperglycemia in coronary heart disease: frequency and associated lipid and lipoprotein levels in the Bezafibrate Infarction Prevention (BIP) registerJournal of Cardiovascular Risk, 1995
- Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)The American Journal of Cardiology, 1993
- Diabetes Mellitus and Macrovascular Complications: An epidemiological perspectiveDiabetes Care, 1992
- Joint discussionJournal of Chronic Diseases, 1979
- Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabeticsDiabetologia, 1977